Trade SLS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
SELLAS Life Sciences Group, Inc. (SLS) is trading at US$11.55, down 14.42% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$3.12B. Over the past 52 weeks, SLS has traded between US$1.39 and US$15.88. On Syfe you can trade SLS with $0 commission and add it to your watchlist.
| Previous close | US$13.49 |
|---|---|
| Market cap | US$3.12B |
| 52-week range | US$1.39 – US$15.88 |
| Volume | 14.71M |
| Exchange | US |
Add to Watchlist
Set Price Alert
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
Year: 2008
Sellas Life Sciences Q2 Loss Narrows
Aug 11, 8:49 PM · MT Newswires
-- Earnings Flash (SLS) SELLAS Life Sciences Posts Q2 Loss $0.05, vs. FactSet Est of $0.05 Loss
Aug 11, 8:31 PM · MT Newswires
Social Buzz: Wallstreetbets Stocks Advance Premarket Monday; SELLAS Life Sciences, Strategy to Open Higher
Jun 29, 10:40 AM · MT Newswires
SELLAS Life Sciences Group, Inc. (SLS) stock is trading at US$11.55, -14.42% from the previous close of US$13.49.
The market cap for SELLAS Life Sciences Group, Inc. (SLS) stock is approximately US$3.12B.
The 52-week high for SELLAS Life Sciences Group, Inc. (SLS) stock is US$15.88.
The 52-week low for SELLAS Life Sciences Group, Inc. (SLS) stock is US$1.39.
SELLAS Life Sciences Group, Inc. (SLS) does not currently pay a dividend.
Stay on top of SLS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
